Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/29/2025

Survival Rates for Mucinous Ovarian Carcinoma

Introduction to Mucinous Ovarian Carcinoma

  • Patients with mucinous ovarian carcinoma have a 5-year disease-specific survival rate of approximately 80-90% overall, with excellent prognosis in early-stage disease but significantly worse outcomes in advanced stages 1

Clinical Presentation and Diagnosis

  • MOC typically presents at a younger age (20-40 years) than high-grade serous ovarian cancer 1
  • MOC often presents as large cystic masses that may fill the entire abdominal-pelvic cavity 1
  • Additional workup for suspected MOC should include gastrointestinal tract evaluation and CEA level to distinguish primary from metastatic disease 1, 2

Treatment and Management

  • For patients with stage IA or IB mucinous tumors, postoperative observation and monitoring are recommended as most of these tumors are benign or borderline 1

REFERENCES

1

ovarian cancer, version 1.2016, nccn clinical practice guidelines in oncology. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2016

2

Diagnostic Approach for Suprapubic Soft Mass [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025